NanoVibronix, Inc. (NAOV) financial statements (2020 and earlier)

Company profile

Business Address 525 EXECUTIVE BLVD
ELMSFORD, NY 10523
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 8964,3601061,614
Cash and cash equivalents 8964,3601061,614
Receivables 1442465
Inventory, net of allowances, customer advances and progress billings 144766771
Inventory 144766771
Prepaid expense 42453450
Other undisclosed current assets 411836
Total current assets: 1,2304,5162211,776
Noncurrent Assets
Property, plant and equipment 861110
Prepaid expense  55 
Other undisclosed noncurrent assets 346338257197
Total noncurrent assets: 354349273207
Other undisclosed assets (4)   
TOTAL ASSETS: 1,5804,8654941,983
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities  797565297
Accounts payable  1688258
Accrued liabilities  1509947
Employee-related liabilities  21917095
Taxes payable  26021497
Other undisclosed current liabilities 640   
Total current liabilities: 640797565297
Noncurrent Liabilities
Liabilities, other than long-term debt 477434349199
Accounts payable and accrued liabilities 477434349199
Other undisclosed noncurrent liabilities 640 2,0791,696
Total noncurrent liabilities: 1,1174342,4281,895
Other undisclosed liabilities (640)   
Total liabilities: 1,1171,2312,9932,192
Stockholders' equity
Stockholders' equity attributable to parent, including: 4633,634(2,499)(209)
Common stock 4422
Additional paid in capital 32,99332,01020,07319,521
Accumulated deficit (32,563)(28,382)(22,576)(19,734)
Other undisclosed stockholders' equity attributable to parent 29222
Total stockholders' equity: 4633,634(2,499)(209)
TOTAL LIABILITIES AND EQUITY: 1,5804,8654941,983

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 318239229147
Revenue, net437  
Cost of revenue (158)(88)(88)(49)
Cost of goods and services sold    (8)
Gross profit: 16015114198
Operating expenses (4,463)(3,242)(2,457)(1,523)
Other undisclosed operating income    1
Operating loss: (4,303)(3,091)(2,316)(1,424)
Nonoperating expense
(Other Nonoperating expense)
 (22)(1,836)(398)(1,432)
Interest and debt expense  (37) (65)
Loss from continuing operations before equity method investments, income taxes: (4,325)(4,964)(2,714)(2,921)
Other undisclosed income from continuing operations before income taxes 4437 65
Loss from continuing operations before income taxes: (4,281)(4,927)(2,714)(2,856)
Income tax expense (benefit) 127(38)(117)(28)
Net loss attributable to parent: (4,154)(4,965)(2,831)(2,884)
Preferred stock dividends and other adjustments  (841)  
Net loss available to common stockholders, diluted: (4,154)(5,806)(2,831)(2,884)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (4,154)(4,965)(2,831)(2,884)
Comprehensive loss: (4,154)(4,965)(2,831)(2,884)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (841)  
Comprehensive loss, net of tax, attributable to parent: (4,154)(5,806)(2,831)(2,884)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: